BIOMAT Database Logo BIOMAT Database Logo

Thalidomide inhibits the replication of human immunodeficiency virus type 1. 1993

S Makonkawkeyoon, and R N Limson-Pobre, and A L Moreira, and V Schauf, and G Kaplan
Rockefeller University, New York, NY 10021.

Thalidomide, a selective inhibitor of tumor necrosis factor alpha (TNF-alpha) synthesis, suppresses the activation of latent human immunodeficiency virus type 1 (HIV-1) in a monocytoid (U1) line. The inhibition is dose dependent and occurs after exposure of the cells to recombinant TNF-alpha, phorbol myristate acetate, lipopolysaccharide, and other cytokine combinations. Associated with HIV-1 inhibition is a reduction in agonist-induced TNF-alpha protein and mRNA production. Thalidomide inhibition of virus replication in the phorbol myristate acetate- and recombinant TNF-alpha-stimulated T-cell line ACH-2 is not observed. The presence of thalidomide also inhibits the activation of virus in the peripheral blood mononuclear cells of 16 out of 17 patients with advanced HIV-1 infection and AIDS. These results suggest the use of thalidomide in a clinical setting to inhibit both virus replication and the TNF-alpha-induced systemic toxicity of HIV-1 and opportunistic infections.

UI MeSH Term Description Entries
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

S Makonkawkeyoon, and R N Limson-Pobre, and A L Moreira, and V Schauf, and G Kaplan
Hepatitis C virus core protein inhibits human immunodeficiency virus type 1 replication.
December 1996, Virus research,
S Makonkawkeyoon, and R N Limson-Pobre, and A L Moreira, and V Schauf, and G Kaplan
Human herpesvirus 6 inhibits human immunodeficiency virus type 1 replication in cell culture.
October 1990, Journal of clinical microbiology,
S Makonkawkeyoon, and R N Limson-Pobre, and A L Moreira, and V Schauf, and G Kaplan
Expression of the human immunodeficiency virus type 1 primer binding sequence inhibits HIV-1 replication.
March 1998, Human gene therapy,
S Makonkawkeyoon, and R N Limson-Pobre, and A L Moreira, and V Schauf, and G Kaplan
Alpha interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle.
March 1992, Journal of virology,
S Makonkawkeyoon, and R N Limson-Pobre, and A L Moreira, and V Schauf, and G Kaplan
Retinoid-induced repression of human immunodeficiency virus type 1 core promoter activity inhibits virus replication.
July 1998, Journal of virology,
S Makonkawkeyoon, and R N Limson-Pobre, and A L Moreira, and V Schauf, and G Kaplan
Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1.
January 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
S Makonkawkeyoon, and R N Limson-Pobre, and A L Moreira, and V Schauf, and G Kaplan
Fangchinoline inhibits human immunodeficiency virus type 1 replication by interfering with gp160 proteolytic processing.
January 2012, PloS one,
S Makonkawkeyoon, and R N Limson-Pobre, and A L Moreira, and V Schauf, and G Kaplan
Human SMOOTHENED inhibits human immunodeficiency virus type 1 infection.
November 2017, Biochemical and biophysical research communications,
S Makonkawkeyoon, and R N Limson-Pobre, and A L Moreira, and V Schauf, and G Kaplan
Human immunodeficiency virus type-1 infection inhibits autophagy.
March 2008, AIDS (London, England),
S Makonkawkeyoon, and R N Limson-Pobre, and A L Moreira, and V Schauf, and G Kaplan
The nontoxic tripeptide glycyl-prolyl-glycine amide inhibits the replication of human immunodeficiency virus type 1.
January 2001, Journal of human virology,
Copied contents to your clipboard!